Selinexor with ruxolitinib demonstrated encouraging efficacy with a manageable safety profile in patients with myelofibrosis ...

This is especially true of women. Data from the Centers for Disease Control and Prevention shows that 61 percent of women ...

A mysterious illness, dubbed disease X, has killed at least 31 people — mostly children — in the remote Panzi region of the ...

While there's no cure yet for Alzheimer's, researchers are finally making more progress in better understanding the disease ...

A new approach to treat rosacea and other inflammatory skin conditions could be on the horizon, according to a University of ...

An analysis indicated that physician assistants in rheumatology are growing at a modest pace and can positively affect the ...

Brittany Lancellotti, DVM, DACVD, talks about available treatment options for flea allergies, environmental allergies, and more ...

About half of people with "chronic spontaneous urticaria," or CSU, the most common type of chronic hives, experience what ...

STOMP is a randomized, controlled, double-blind trial to evaluate the safety and effectiveness of Tpoxx for treating mpox. In ...

A sign you're the scapegoat kid in a dysfunctional family is being blamed for how other people act or being held responsible ...

Avidity Biosciences' AOC platform shows promising results for genetic diseases, making it a strong buy with potential upside ...

NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for Evidence-Based Psychiatry ...